Skip to content
10-Q

Quarterly Report

Cantabio Pharmaceuticals Inc.

0001654954-17-010590

← back to feed
Filed
Nov 14, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Sep 30, 2017 27.1M sh
Stockholders Equity Q2 2018 · Sep 30, 2017 −$1.45M
Stockholders Equity Q2 2018 · Mar 31, 2017 −$853.92K
Current Liabilities Q2 2018 · Sep 30, 2017 $1.5M
Current Liabilities Q2 2018 · Mar 31, 2017 $887.45K
Total Liabilities Q2 2018 · Sep 30, 2017 $1.5M
Total Liabilities Q2 2018 · Mar 31, 2017 $887.45K
Current Assets Q2 2018 · Sep 30, 2017 $51.2K
Current Assets Q2 2018 · Mar 31, 2017 $33.52K
Total Assets Q2 2018 · Sep 30, 2017 $51.2K
Total Assets Q2 2018 · Mar 31, 2017 $33.52K
Operating Cash Flow Q2 2018 · Sep 30, 2016 −$519.18K
Cash And Equivalents Q2 2018 · Sep 30, 2016 $12.63K
Cash And Equivalents Q2 2018 · Mar 31, 2016 $52.11K
Sga Expense Q2 2018 · Sep 30, 2016 $218.52K
Sga Expense Q2 2018 · Sep 30, 2016 $372.85K
Rd Expense Q2 2018 · Sep 30, 2016 $69.07K
Rd Expense Q2 2018 · Sep 30, 2016 $181.8K
Net Income Q2 2018 · Sep 30, 2016 −$293.55K
Net Income Q2 2018 · Sep 30, 2016 −$559.42K